Global Cancer Gene Therapy Market Size, Status and Forecast 2024-2031

Report ID: 954167 | Published Date: Apr 2024 | No. of Page: 109 | Base Year: 2023 | Rating: 3.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Cancer Gene Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Oncolytic Virotherapy
        1.2.3 Gene Transfer
        1.2.4 Gene-Induced Immunotherapy
    1.3 Market by Application
        1.3.1 Global Cancer Gene Therapy Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospitals
        1.3.3 Diagnostics Centers
        1.3.4 Research Institutes
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Cancer Gene Therapy Market Perspective (2016-2027)
    2.2 Cancer Gene Therapy Growth Trends by Regions
        2.2.1 Cancer Gene Therapy Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Cancer Gene Therapy Historic Market Share by Regions (2016-2021)
        2.2.3 Cancer Gene Therapy Forecasted Market Size by Regions (2022-2027)
    2.3 Cancer Gene Therapy Industry Dynamic
        2.3.1 Cancer Gene Therapy Market Trends
        2.3.2 Cancer Gene Therapy Market Drivers
        2.3.3 Cancer Gene Therapy Market Challenges
        2.3.4 Cancer Gene Therapy Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Cancer Gene Therapy Players by Revenue
        3.1.1 Global Top Cancer Gene Therapy Players by Revenue (2016-2021)
        3.1.2 Global Cancer Gene Therapy Revenue Market Share by Players (2016-2021)
    3.2 Global Cancer Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Cancer Gene Therapy Revenue
    3.4 Global Cancer Gene Therapy Market Concentration Ratio
        3.4.1 Global Cancer Gene Therapy Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Cancer Gene Therapy Revenue in 2020
    3.5 Cancer Gene Therapy Key Players Head office and Area Served
    3.6 Key Players Cancer Gene Therapy Product Solution and Service
    3.7 Date of Enter into Cancer Gene Therapy Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Cancer Gene Therapy Breakdown Data by Type
    4.1 Global Cancer Gene Therapy Historic Market Size by Type (2016-2021)
    4.2 Global Cancer Gene Therapy Forecasted Market Size by Type (2022-2027)

5 Cancer Gene Therapy Breakdown Data by Application
    5.1 Global Cancer Gene Therapy Historic Market Size by Application (2016-2021)
    5.2 Global Cancer Gene Therapy Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Cancer Gene Therapy Market Size (2016-2027)
    6.2 North America Cancer Gene Therapy Market Size by Type
        6.2.1 North America Cancer Gene Therapy Market Size by Type (2016-2021)
        6.2.2 North America Cancer Gene Therapy Market Size by Type (2022-2027)
        6.2.3 North America Cancer Gene Therapy Market Size by Type (2016-2027)
    6.3 North America Cancer Gene Therapy Market Size by Application
        6.3.1 North America Cancer Gene Therapy Market Size by Application (2016-2021)
        6.3.2 North America Cancer Gene Therapy Market Size by Application (2022-2027)
        6.3.3 North America Cancer Gene Therapy Market Size by Application (2016-2027)
    6.4 North America Cancer Gene Therapy Market Size by Country
        6.4.1 North America Cancer Gene Therapy Market Size by Country (2016-2021)
        6.4.2 North America Cancer Gene Therapy Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Cancer Gene Therapy Market Size (2016-2027)
    7.2 Europe Cancer Gene Therapy Market Size by Type
        7.2.1 Europe Cancer Gene Therapy Market Size by Type (2016-2021)
        7.2.2 Europe Cancer Gene Therapy Market Size by Type (2022-2027)
        7.2.3 Europe Cancer Gene Therapy Market Size by Type (2016-2027)
    7.3 Europe Cancer Gene Therapy Market Size by Application
        7.3.1 Europe Cancer Gene Therapy Market Size by Application (2016-2021)
        7.3.2 Europe Cancer Gene Therapy Market Size by Application (2022-2027)
        7.3.3 Europe Cancer Gene Therapy Market Size by Application (2016-2027)
    7.4 Europe Cancer Gene Therapy Market Size by Country
        7.4.1 Europe Cancer Gene Therapy Market Size by Country (2016-2021)
        7.4.2 Europe Cancer Gene Therapy Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Cancer Gene Therapy Market Size (2016-2027)
    8.2 Asia-Pacific Cancer Gene Therapy Market Size by Type
        8.2.1 Asia-Pacific Cancer Gene Therapy Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Cancer Gene Therapy Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Cancer Gene Therapy Market Size by Type (2016-2027)
    8.3 Asia-Pacific Cancer Gene Therapy Market Size by Application
        8.3.1 Asia-Pacific Cancer Gene Therapy Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Cancer Gene Therapy Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Cancer Gene Therapy Market Size by Application (2016-2027)
    8.4 Asia-Pacific Cancer Gene Therapy Market Size by Region
        8.4.1 Asia-Pacific Cancer Gene Therapy Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Cancer Gene Therapy Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Cancer Gene Therapy Market Size (2016-2027)
    9.2 Latin America Cancer Gene Therapy Market Size by Type
        9.2.1 Latin America Cancer Gene Therapy Market Size by Type (2016-2021)
        9.2.2 Latin America Cancer Gene Therapy Market Size by Type (2022-2027)
        9.2.3 Latin America Cancer Gene Therapy Market Size by Type (2016-2027)
    9.3 Latin America Cancer Gene Therapy Market Size by Application
        9.3.1 Latin America Cancer Gene Therapy Market Size by Application (2016-2021)
        9.3.2 Latin America Cancer Gene Therapy Market Size by Application (2022-2027)
        9.3.3 Latin America Cancer Gene Therapy Market Size by Application (2016-2027)
    9.4 Latin America Cancer Gene Therapy Market Size by Country
        9.4.1 Latin America Cancer Gene Therapy Market Size by Country (2016-2021)
        9.4.2 Latin America Cancer Gene Therapy Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Cancer Gene Therapy Market Size (2016-2027)
    10.2 Middle East & Africa Cancer Gene Therapy Market Size by Type
        10.2.1 Middle East & Africa Cancer Gene Therapy Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Cancer Gene Therapy Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Cancer Gene Therapy Market Size by Type (2016-2027)
    10.3 Middle East & Africa Cancer Gene Therapy Market Size by Application
        10.3.1 Middle East & Africa Cancer Gene Therapy Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Cancer Gene Therapy Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Cancer Gene Therapy Market Size by Application (2016-2027)
    10.4 Middle East & Africa Cancer Gene Therapy Market Size by Country
        10.4.1 Middle East & Africa Cancer Gene Therapy Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Cancer Gene Therapy Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Adaptimmune
        11.1.1 Adaptimmune Company Details
        11.1.2 Adaptimmune Business Overview
        11.1.3 Adaptimmune Cancer Gene Therapy Introduction
        11.1.4 Adaptimmune Revenue in Cancer Gene Therapy Business (2016-2021)
        11.1.5 Adaptimmune Recent Development
    11.2 Bluebird bio
        11.2.1 Bluebird bio Company Details
        11.2.2 Bluebird bio Business Overview
        11.2.3 Bluebird bio Cancer Gene Therapy Introduction
        11.2.4 Bluebird bio Revenue in Cancer Gene Therapy Business (2016-2021)
        11.2.5 Bluebird bio Recent Development
    11.3 Celgene
        11.3.1 Celgene Company Details
        11.3.2 Celgene Business Overview
        11.3.3 Celgene Cancer Gene Therapy Introduction
        11.3.4 Celgene Revenue in Cancer Gene Therapy Business (2016-2021)
        11.3.5 Celgene Recent Development
    11.4 Shanghai Sunway Biotech
        11.4.1 Shanghai Sunway Biotech Company Details
        11.4.2 Shanghai Sunway Biotech Business Overview
        11.4.3 Shanghai Sunway Biotech Cancer Gene Therapy Introduction
        11.4.4 Shanghai Sunway Biotech Revenue in Cancer Gene Therapy Business (2016-2021)
        11.4.5 Shanghai Sunway Biotech Recent Development
    11.5 Shenzhen SiBiono GeneTech
        11.5.1 Shenzhen SiBiono GeneTech Company Details
        11.5.2 Shenzhen SiBiono GeneTech Business Overview
        11.5.3 Shenzhen SiBiono GeneTech Cancer Gene Therapy Introduction
        11.5.4 Shenzhen SiBiono GeneTech Revenue in Cancer Gene Therapy Business (2016-2021)
        11.5.5 Shenzhen SiBiono GeneTech Recent Development
    11.6 SynerGene Therapeutics
        11.6.1 SynerGene Therapeutics Company Details
        11.6.2 SynerGene Therapeutics Business Overview
        11.6.3 SynerGene Therapeutics Cancer Gene Therapy Introduction
        11.6.4 SynerGene Therapeutics Revenue in Cancer Gene Therapy Business (2016-2021)
        11.6.5 SynerGene Therapeutics Recent Development
    11.7 Altor BioScience
        11.7.1 Altor BioScience Company Details
        11.7.2 Altor BioScience Business Overview
        11.7.3 Altor BioScience Cancer Gene Therapy Introduction
        11.7.4 Altor BioScience Revenue in Cancer Gene Therapy Business (2016-2021)
        11.7.5 Altor BioScience Recent Development
    11.8 Amgen
        11.8.1 Amgen Company Details
        11.8.2 Amgen Business Overview
        11.8.3 Amgen Cancer Gene Therapy Introduction
        11.8.4 Amgen Revenue in Cancer Gene Therapy Business (2016-2021)
        11.8.5 Amgen Recent Development
    11.9 Argenx
        11.9.1 Argenx Company Details
        11.9.2 Argenx Business Overview
        11.9.3 Argenx Cancer Gene Therapy Introduction
        11.9.4 Argenx Revenue in Cancer Gene Therapy Business (2016-2021)
        11.9.5 Argenx Recent Development
    11.10 BioCancell
        11.10.1 BioCancell Company Details
        11.10.2 BioCancell Business Overview
        11.10.3 BioCancell Cancer Gene Therapy Introduction
        11.10.4 BioCancell Revenue in Cancer Gene Therapy Business (2016-2021)
        11.10.5 BioCancell Recent Development
    11.11 GlaxoSmithKline
        11.11.1 GlaxoSmithKline Company Details
        11.11.2 GlaxoSmithKline Business Overview
        11.11.3 GlaxoSmithKline Cancer Gene Therapy Introduction
        11.11.4 GlaxoSmithKline Revenue in Cancer Gene Therapy Business (2016-2021)
        11.11.5 GlaxoSmithKline Recent Development
    11.12 Merck
        11.12.1 Merck Company Details
        11.12.2 Merck Business Overview
        11.12.3 Merck Cancer Gene Therapy Introduction
        11.12.4 Merck Revenue in Cancer Gene Therapy Business (2016-2021)
        11.12.5 Merck Recent Development
    11.13 OncoGenex Pharmaceuticals
        11.13.1 OncoGenex Pharmaceuticals Company Details
        11.13.2 OncoGenex Pharmaceuticals Business Overview
        11.13.3 OncoGenex Pharmaceuticals Cancer Gene Therapy Introduction
        11.13.4 OncoGenex Pharmaceuticals Revenue in Cancer Gene Therapy Business (2016-2021)
        11.13.5 OncoGenex Pharmaceuticals Recent Development
    11.14 Transgene
        11.14.1 Transgene Company Details
        11.14.2 Transgene Business Overview
        11.14.3 Transgene Cancer Gene Therapy Introduction
        11.14.4 Transgene Revenue in Cancer Gene Therapy Business (2016-2021)
        11.14.5 Transgene Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Cancer Gene Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Oncolytic Virotherapy
    Table 3. Key Players of Gene Transfer
    Table 4. Key Players of Gene-Induced Immunotherapy
    Table 5. Global Cancer Gene Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Cancer Gene Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Cancer Gene Therapy Market Size by Regions (2016-2021) & (US$ Million)
    Table 8. Global Cancer Gene Therapy Market Share by Regions (2016-2021)
    Table 9. Global Cancer Gene Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 10. Global Cancer Gene Therapy Market Share by Regions (2022-2027)
    Table 11. Cancer Gene Therapy Market Trends
    Table 12. Cancer Gene Therapy Market Drivers
    Table 13. Cancer Gene Therapy Market Challenges
    Table 14. Cancer Gene Therapy Market Restraints
    Table 15. Global Cancer Gene Therapy Revenue by Players (2016-2021) & (US$ Million)
    Table 16. Global Cancer Gene Therapy Market Share by Players (2016-2021)
    Table 17. Global Top Cancer Gene Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Gene Therapy as of 2020)
    Table 18. Ranking of Global Top Cancer Gene Therapy Companies by Revenue (US$ Million) in 2020
    Table 19. Global 5 Largest Players Market Share by Cancer Gene Therapy Revenue (CR5 and HHI) & (2016-2021)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Cancer Gene Therapy Product Solution and Service
    Table 22. Date of Enter into Cancer Gene Therapy Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Cancer Gene Therapy Market Size by Type (2016-2021) (US$ Million)
    Table 25. Global Cancer Gene Therapy Revenue Market Share by Type (2016-2021)
    Table 26. Global Cancer Gene Therapy Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 27. Global Cancer Gene Therapy Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 28. Global Cancer Gene Therapy Market Size Share by Application (2016-2021) & (US$ Million)
    Table 29. Global Cancer Gene Therapy Revenue Market Share by Application (2016-2021)
    Table 30. Global Cancer Gene Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 31. Global Cancer Gene Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 32. North America Cancer Gene Therapy Market Size by Type (2016-2021) (US$ Million)
    Table 33. North America Cancer Gene Therapy Market Size by Type (2022-2027) & (US$ Million)
    Table 34. North America Cancer Gene Therapy Market Size by Application (2016-2021) (US$ Million)
    Table 35. North America Cancer Gene Therapy Market Size by Application (2022-2027) & (US$ Million)
    Table 36. North America Cancer Gene Therapy Market Size by Country (2016-2021) & (US$ Million) 
    Table 37. North America Cancer Gene Therapy Market Size by Country (2022-2027) & (US$ Million) 
    Table 38. Europe Cancer Gene Therapy Market Size by Type (2016-2021) (US$ Million)
    Table 39. Europe Cancer Gene Therapy Market Size by Type (2022-2027) & (US$ Million)
    Table 40. Europe Cancer Gene Therapy Market Size by Application (2016-2021) (US$ Million)
    Table 41. Europe Cancer Gene Therapy Market Size by Application (2022-2027) & (US$ Million)
    Table 42. Europe Cancer Gene Therapy Market Size by Country (2016-2021) & (US$ Million) 
    Table 43. Europe Cancer Gene Therapy Market Size by Country (2022-2027) & (US$ Million) 
    Table 44. Asia-Pacific Cancer Gene Therapy Market Size by Type (2016-2021) (US$ Million)
    Table 45. Asia-Pacific Cancer Gene Therapy Market Size by Type (2022-2027) & (US$ Million)
    Table 46. Asia-Pacific Cancer Gene Therapy Market Size by Application (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Cancer Gene Therapy Market Size by Application (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Cancer Gene Therapy Market Size by Region (2016-2021) & (US$ Million) 
    Table 49. Asia-Pacific Cancer Gene Therapy Market Size by Region (2022-2027) & (US$ Million) 
    Table 50. Latin America Cancer Gene Therapy Market Size by Type (2016-2021) (US$ Million)
    Table 51. Latin America Cancer Gene Therapy Market Size by Type (2022-2027) & (US$ Million)
    Table 52. Latin America Cancer Gene Therapy Market Size by Application (2016-2021) (US$ Million)
    Table 53. Latin America Cancer Gene Therapy Market Size by Application (2022-2027) & (US$ Million)
    Table 54. Latin America Cancer Gene Therapy Market Size by Country (2016-2021) & (US$ Million) 
    Table 55. Latin America Cancer Gene Therapy Market Size by Country (2022-2027) & (US$ Million) 
    Table 56. Middle East & Africa Cancer Gene Therapy Market Size by Type (2016-2021) (US$ Million)
    Table 57. Middle East & Africa Cancer Gene Therapy Market Size by Type (2022-2027) & (US$ Million)
    Table 58. Middle East & Africa Cancer Gene Therapy Market Size by Application (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Cancer Gene Therapy Market Size by Application (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Cancer Gene Therapy Market Size by Country (2016-2021) & (US$ Million) 
    Table 61. Middle East & Africa Cancer Gene Therapy Market Size by Country (2022-2027) & (US$ Million) 
    Table 62. Adaptimmune Company Details
    Table 63. Adaptimmune Business Overview
    Table 64. Adaptimmune Cancer Gene Therapy Product
    Table 65. Adaptimmune Revenue in Cancer Gene Therapy Business (2016-2021) & (US$ Million)
    Table 66. Adaptimmune Recent Development
    Table 67. Bluebird bio Company Details
    Table 68. Bluebird bio Business Overview
    Table 69. Bluebird bio Cancer Gene Therapy Product
    Table 70. Bluebird bio Revenue in Cancer Gene Therapy Business (2016-2021) & (US$ Million)
    Table 71. Bluebird bio Recent Development
    Table 72. Celgene Company Details
    Table 73. Celgene Business Overview
    Table 74. Celgene Cancer Gene Therapy Product
    Table 75. Celgene Revenue in Cancer Gene Therapy Business (2016-2021) & (US$ Million)
    Table 76. Celgene Recent Development
    Table 77. Shanghai Sunway Biotech Company Details
    Table 78. Shanghai Sunway Biotech Business Overview
    Table 79. Shanghai Sunway Biotech Cancer Gene Therapy Product
    Table 80. Shanghai Sunway Biotech Revenue in Cancer Gene Therapy Business (2016-2021) & (US$ Million)
    Table 81. Shanghai Sunway Biotech Recent Development
    Table 82. Shenzhen SiBiono GeneTech Company Details
    Table 83. Shenzhen SiBiono GeneTech Business Overview
    Table 84. Shenzhen SiBiono GeneTech Cancer Gene Therapy Product
    Table 85. Shenzhen SiBiono GeneTech Revenue in Cancer Gene Therapy Business (2016-2021) & (US$ Million)
    Table 86. Shenzhen SiBiono GeneTech Recent Development
    Table 87. SynerGene Therapeutics Company Details
    Table 88. SynerGene Therapeutics Business Overview
    Table 89. SynerGene Therapeutics Cancer Gene Therapy Product
    Table 90. SynerGene Therapeutics Revenue in Cancer Gene Therapy Business (2016-2021) & (US$ Million)
    Table 91. SynerGene Therapeutics Recent Development
    Table 92. Altor BioScience Company Details
    Table 93. Altor BioScience Business Overview
    Table 94. Altor BioScience Cancer Gene Therapy Product
    Table 95. Altor BioScience Revenue in Cancer Gene Therapy Business (2016-2021) & (US$ Million)
    Table 96. Altor BioScience Recent Development
    Table 97. Amgen Company Details
    Table 98. Amgen Business Overview
    Table 99. Amgen Revenue in Cancer Gene Therapy Business (2016-2021) & (US$ Million)
    Table 100. Amgen Recent Development
    Table 101. Argenx Company Details
    Table 102. Argenx Business Overview
    Table 103. Argenx Cancer Gene Therapy Product
    Table 104. Argenx Revenue in Cancer Gene Therapy Business (2016-2021) & (US$ Million)
    Table 105. Argenx Recent Development
    Table 106. BioCancell Company Details
    Table 107. BioCancell Business Overview
    Table 108. BioCancell Cancer Gene Therapy Product
    Table 109. BioCancell Revenue in Cancer Gene Therapy Business (2016-2021) & (US$ Million)
    Table 110. BioCancell Recent Development
    Table 111. GlaxoSmithKline Company Details
    Table 112. GlaxoSmithKline Business Overview
    Table 113. GlaxoSmithKline Cancer Gene Therapy Product
    Table 114. GlaxoSmithKline Revenue in Cancer Gene Therapy Business (2016-2021) & (US$ Million)
    Table 115. GlaxoSmithKline Recent Development
    Table 116. Merck Company Details
    Table 117. Merck Business Overview
    Table 118. Merck Cancer Gene Therapy Product
    Table 119. Merck Revenue in Cancer Gene Therapy Business (2016-2021) & (US$ Million)
    Table 120. Merck Recent Development
    Table 121. OncoGenex Pharmaceuticals Company Details
    Table 122. OncoGenex Pharmaceuticals Business Overview
    Table 123. OncoGenex Pharmaceuticals Cancer Gene Therapy Product
    Table 124. OncoGenex Pharmaceuticals Revenue in Cancer Gene Therapy Business (2016-2021) & (US$ Million)
    Table 125. OncoGenex Pharmaceuticals Recent Development
    Table 126. Transgene Company Details
    Table 127. Transgene Business Overview
    Table 128. Transgene Cancer Gene Therapy Product
    Table 129. Transgene Revenue in Cancer Gene Therapy Business (2016-2021) & (US$ Million)
    Table 130. Transgene Recent Development
    Table 131. Research Programs/Design for This Report
    Table 132. Key Data Information from Secondary Sources
    Table 133. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Cancer Gene Therapy Market Share by Type: 2020 VS 2027
    Figure 2. Oncolytic Virotherapy Features
    Figure 3. Gene Transfer Features
    Figure 4. Gene-Induced Immunotherapy Features
    Figure 5. Global Cancer Gene Therapy Market Share by Application: 2020 VS 2027
    Figure 6. Hospitals Case Studies
    Figure 7. Diagnostics Centers Case Studies
    Figure 8. Research Institutes Case Studies
    Figure 9. Cancer Gene Therapy Report Years Considered
    Figure 10. Global Cancer Gene Therapy Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 11. Global Cancer Gene Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 12. Global Cancer Gene Therapy Market Share by Regions: 2020 VS 2027
    Figure 13. Global Cancer Gene Therapy Market Share by Regions (2022-2027)
    Figure 14. Global Cancer Gene Therapy Market Share by Players in 2020
    Figure 15. Global Top Cancer Gene Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Gene Therapy as of 2020
    Figure 16. The Top 10 and 5 Players Market Share by Cancer Gene Therapy Revenue in 2020
    Figure 17. Global Cancer Gene Therapy Revenue Market Share by Type (2016-2021)
    Figure 18. Global Cancer Gene Therapy Revenue Market Share by Type (2022-2027)
    Figure 19. North America Cancer Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 20. North America Cancer Gene Therapy Market Share by Type (2016-2027)
    Figure 21. North America Cancer Gene Therapy Market Share by Application (2016-2027)
    Figure 22. North America Cancer Gene Therapy Market Share by Country (2016-2027)
    Figure 23. United States Cancer Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Canada Cancer Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Cancer Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Cancer Gene Therapy Market Share by Type (2016-2027)
    Figure 27. Europe Cancer Gene Therapy Market Share by Application (2016-2027)
    Figure 28. Europe Cancer Gene Therapy Market Share by Country (2016-2027)
    Figure 29. Germany Cancer Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. France Cancer Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. U.K. Cancer Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Italy Cancer Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Russia Cancer Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Nordic Cancer Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Cancer Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Cancer Gene Therapy Market Share by Type (2016-2027)
    Figure 37. Asia-Pacific Cancer Gene Therapy Market Share by Application (2016-2027)
    Figure 38. Asia-Pacific Cancer Gene Therapy Market Share by Region (2016-2027)
    Figure 39. China Cancer Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Japan Cancer Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. South Korea Cancer Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Southeast Asia Cancer Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. India Cancer Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Australia Cancer Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Cancer Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Cancer Gene Therapy Market Share by Type (2016-2027)
    Figure 47. Latin America Cancer Gene Therapy Market Share by Application (2016-2027)
    Figure 48. Latin America Cancer Gene Therapy Market Share by Country (2016-2027)
    Figure 49. Mexico Cancer Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Brazil Cancer Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Cancer Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Cancer Gene Therapy Market Share by Type (2016-2027)
    Figure 53. Middle East & Africa Cancer Gene Therapy Market Share by Application (2016-2027)
    Figure 54. Middle East & Africa Cancer Gene Therapy Market Share by Country (2016-2027)
    Figure 55. Turkey Cancer Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Saudi Arabia Cancer Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. UAE Cancer Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Adaptimmune Revenue Growth Rate in Cancer Gene Therapy Business (2016-2021)
    Figure 59. Bluebird bio Revenue Growth Rate in Cancer Gene Therapy Business (2016-2021)
    Figure 60. Celgene Revenue Growth Rate in Cancer Gene Therapy Business (2016-2021)
    Figure 61. Shanghai Sunway Biotech Revenue Growth Rate in Cancer Gene Therapy Business (2016-2021)
    Figure 62. Shenzhen SiBiono GeneTech Revenue Growth Rate in Cancer Gene Therapy Business (2016-2021)
    Figure 63. SynerGene Therapeutics Revenue Growth Rate in Cancer Gene Therapy Business (2016-2021)
    Figure 64. Altor BioScience Revenue Growth Rate in Cancer Gene Therapy Business (2016-2021)
    Figure 65. Amgen Revenue Growth Rate in Cancer Gene Therapy Business (2016-2021)
    Figure 66. Argenx Revenue Growth Rate in Cancer Gene Therapy Business (2016-2021)
    Figure 67. BioCancell Revenue Growth Rate in Cancer Gene Therapy Business (2016-2021)
    Figure 68. GlaxoSmithKline Revenue Growth Rate in Cancer Gene Therapy Business (2016-2021)
    Figure 69. Merck Revenue Growth Rate in Cancer Gene Therapy Business (2016-2021)
    Figure 70. OncoGenex Pharmaceuticals Revenue Growth Rate in Cancer Gene Therapy Business (2016-2021)
    Figure 71. Transgene Revenue Growth Rate in Cancer Gene Therapy Business (2016-2021)
    Figure 72. Bottom-up and Top-down Approaches for This Report
    Figure 73. Data Triangulation
    Figure 74. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Adaptimmune
Bluebird bio
Celgene
Shanghai Sunway Biotech
Shenzhen SiBiono GeneTech
SynerGene Therapeutics
Altor BioScience
Amgen
Argenx
BioCancell
GlaxoSmithKline
Merck
OncoGenex Pharmaceuticals
Transgene
Frequently Asked Questions
Cancer Gene Therapy report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Cancer Gene Therapy report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Cancer Gene Therapy report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Cannabis Testing

Cannabis testing defines various drug test methods for the usage of cannabis in medical prescript ... Read More

Green Packaging

Packaging is an important characteristic that helps in attracting customers. Brands and products  ... Read More

Green Technology

Green technology is a concept that promotes the creation and adoption of new technologies and inn ... Read More